FDA Inspection 1306358 — Phil Inter Pharma USA, Inc.
The FDA completed an inspection of Phil Inter Pharma USA, Inc. on January 29, 2026 in Rancho Cucamonga, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 29, 2026
- Fiscal Year
- 2026
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Rancho Cucamonga, CA (United States)